Severe hyperkalaemia with prescription of potassium-retaining agents in an elderly patient

New Zealand Medical Journal

Volumn 116, Issue 1179, 2003, Pages

  Martin, Jennifer H ^a   Mourton, Susannah M ^a   Nicholls, M Gary ^b  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; COTRIMOXAZOLE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FUROSEMIDE; GLUCONATE CALCIUM; GLUCOSE; INSULIN; POLYSTYRENESULFONATE SODIUM; POTASSIUM SPARING DIURETIC AGENT; RENIN; SPIRONOLACTONE; UREA; DIURETIC AGENT; URINARY TRACT ANTIINFECTIVE AGENT;

AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; CASE REPORT; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; ELDERLY CARE; ELECTROCARDIOGRAM; HUMAN; HYPERKALEMIA; MALE; MUSCLE WEAKNESS; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRESCRIPTION; QRS COMPLEX; SINUS BRADYCARDIA; SODIUM RESTRICTION; T WAVE; TREATMENT OUTCOME; UREA BLOOD LEVEL; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFECTIVE AGENTS, URINARY; DIET, SODIUM-RESTRICTED; DIURETICS; DRUG INTERACTIONS; HUMANS; HYPERKALEMIA; MALE;

EID: 0142009625     PISSN: 11758716     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Maslowski AH, Ikram H, Nicholls MG, Espiner EA. Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure. Lancet 1981;1:71-4.
2. Ikram H, Webster MW, Nicholls MG, et al. Combined spironolactone and converting-enzyme inhibitor therapy for refractory heart failure. Aust NZ J Med 1986;16:61-3.
3. Lakhani M. Complete heart block induced by hyperkalaemia associated with treatment with a combination of captopril and spironolactone. Br Med J 1986;293:271.
4. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-17.
5. Georges B, Beguin C, Jadoul M. Spironolactone and congestive heart failure. Lancet 2000;355:1369-70.
6. Schepkens H, Vanholder R, Billiouw JM, Lameire N. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases. Am J Med 2001;110:438-41.
7. Bozkurt B, Agoston I, Knowlton AA. Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines. J Am Coll Cardiol 2003;41:211-4.
8. Perazella MA, Mahnensmith RL. Trimethoprim-sulfamethoxazole: hyperkalemia is an important complication regardless of dose. Clin Nephrol 1996;46:187-92.
9. Bugge JF. Severe hyperkalaemia induced by trimethoprim in combination with an angiotensin-converting enzyme inhibitor in a patient with transplanted lungs. J Int Med 1996;240:249-51.
10. Biswas K, Mulkerrin EC. Potassium homoeostasis in the elderly. QJM 1997;90:487-92.